↓ Skip to main content

Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial

Overview of attention for article published in Malaria Journal, December 2012
Altmetric Badge

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial
Published in
Malaria Journal, December 2012
DOI 10.1186/1475-2875-11-416
Pubmed ID
Authors

Roger CK Tine, Babacar Faye, Khadime Sylla, Jean L Ndiaye, Magatte Ndiaye, Doudou Sow, Aminata C Lo, Annie Abiola, Mamadou C Ba, Oumar Gaye

Abstract

Prompt treatment of malaria attacks with arteminisin-based combination therapy (ACT) is an essential tool for malaria control. A new co-blister tablet of artesunate-mefloquine (AM) with 25 mg/kg mefloquine has been developed for the management of uncomplicated malaria attacks. This non-inferiority randomized trial, was conducted to evaluate the efficacy and safety of the new formulation of AM in comparison to artemether-lumefantrine (AL) for the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in Senegal.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Unknown 49 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 20%
Student > Master 7 14%
Researcher 7 14%
Other 5 10%
Student > Doctoral Student 4 8%
Other 10 20%
Unknown 7 14%
Readers by discipline Count As %
Medicine and Dentistry 19 38%
Agricultural and Biological Sciences 7 14%
Psychology 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Mathematics 2 4%
Other 6 12%
Unknown 11 22%